Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.

Oncology (Williston Park, N.Y.) - 15 Mar 2017

Pishvaian Michael J, Brody Jonathan R

Abstract excerpt

The prognosis of metastatic pancreatic adenocarcinoma has recently begun to improve. In the last several years, first-line therapy with gemcitabine plus nab-paclitaxel or a regimen of fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) has boosted the median overall survival (OS) duration to 8.5 months and 11 months, respectively, in patients with metastatic pancreatic cancer, compared with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents
Share to Molecular Diagnostic Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Pancreatic Neoplasms

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Identifiers

PMID: 28299752

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.PMID 28299752Read ↗

Clinical utility of molecular subtyping of pancreatic cancerSemantic proximity Read ↗

Pancreatic cancer subtyping - the keystone of precision treatmentSemantic proximity Read ↗

Clinical Impact of Molecular Subtyping of Pancreatic CancerSemantic proximity Read ↗

Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.Semantic proximity Read ↗

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.Semantic proximity Read ↗

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read ↗

Molecular biology of pancreatic cancer.Semantic proximity Read ↗

Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?Semantic proximity Read ↗

Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.Semantic proximity Read ↗

Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.Semantic proximity Read ↗

Molecular biology of pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.